“CPX-351 New Horizon in the Management of t-AML & AML-MRC” is an announced online webinar in the Saudi Society of Blood & Marrow Transplantation Webinar Series, scheduled for Saturday, 28 November 2026. The official material focuses on therapy-related acute myeloid leukemia and AML with myelodysplasia-related changes. The society’s poster displays Biologix as a supporting company; the listing is therefore explicitly industry-supported and does not carry a verified CME badge or an inferred accreditation award.
Scientific programme. The printed schedule opens at 8:00 PM KSA time with introduction and welcome remarks from Dr. Ahmed Alaskar and Dr. Bader Alahmari, ending at 8:05 PM. Professor Thomas Schroeder presents “High-Risk AML: Optimizing the Pathway to Allogeneic Transplant” between 8:05 and 8:45 PM. Dr. Anas Alsuraihi then leads “Best Practice in Management of Secondary AML Cases” from 8:45 to 9:05 PM. The final discussion and question-and-answer session with all faculty is shown from 9:05 to 9:15 PM.
Published faculty. Professor Thomas Schroeder is a professor for translational allogeneic stem cell transplantation and senior consultant at University Hospital Essen, Germany. Dr. Anas Alsuraihi is a consultant in adult hematology and bone marrow transplantation at Princess Noorah Oncology Center, King Abdulaziz Medical City, Jeddah. Moderator Dr. Bader Ali Alahmari works in stem cell transplantation and cellular therapy at King Abdulaziz Medical City, Riyadh, and chairs the Blood and Cancer Research Department at KAIMRC. Chairman Dr. Ahmed Alaskar is Professor and Consultant in Adult Hematology and HSCT and Executive Director of KAIMRC.
Attendance and timing. This is an online-only event. The organiser’s website summary says 8:00–9:00 PM KSA, but the official poster’s programme continues to 9:15 PM; both are disclosed, with the complete printed timetable retained. The organiser explicitly says registration is not yet open, so there is no active webinar registration URL in this listing.
Four faculty are published; no additional participants are invented. A programme PDF, workshop, event-specific abstract call, fee table and confirmed positive accreditation hours are not available in the accessible announcement. General society terms are not treated as proof of this webinar’s fees or credit approval.
